Abbott Abbokinase "Dear Doctor" Letter Draws Warning From FDA

Abbott's characterization of its Abbokinase manufacturing upgrades in recent correspondence to health care professionals has drawn a warning letter from FDA.

More from Archive

More from Pink Sheet